The event Fourth Annual Counseling Workshop for Careers in Biotechnology and Medical Devices will take place at Joe Rindone Regional Technology Center, San Diego County Office of Education, 6401 Linda Vista Road, San Diego, CA 92111 from 12-4 p.m. on Tuesday, March 13, 2007. Program attendance is limited to career counselers and related professionals and registration is free (but required). The program will provide of an overview of the industry and views from the "bench" and the "desk."
Category:
Biotech Industry Events |
Comments Off on Fourth Annual Counseling Workshop for Careers in Biotechnology and Medical Devices
The Second Annual Stem Cell Meeting will be held on March 12-13, 2007 at the Mission Bay Conference Center at the University of California, San Francisco. This event is the premier international event bringing together world-renowned scientists at the frontier of embryonic and adult stem cell research with decision makers and thought leaders in policy, ethics, patient advocacy, finance, business, and media to explore the challenge and promise of the research and the compelling potential of emerging therapies. The speaker list includes:
Marc Beer
President and CEO, ViaCell Inc.
Donald Berry
Chair, Biostatistics, MD Anderson Cancer Research Center
G. Steven Burrill
CEO, Burrill & Company
Bruce Cohen
President and CEO, Cellerant Therapeutics, Inc.
Larry Goldstein
Director, UCSD Stem Cell Institute
David Gollaher
President and CEO,California Healthcare Institute
Zach W. Hall
President and Chief Scientific Officer, CIRM
Marc H. Hedrick
President, Cytori Therapeutics
Michael Krams
President, Adaptive Trials and Clinical Development, Wyeth
Philip Lavori
Chair, Stanford University Center for Health Research and Policy
Greg Lucier
CEO, Invitrogen
Angela McNab
Chief Executive, Human Fertilisation and Embryology Authority (HFEA, UK)
Steven Minger
PhD., Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, King’s College London
Thomas Okarma
President, CEO and Director, Geron Corporation
Mahendra Rao
Vice President, Research, Stem Cells and Regenerative Medicine, Invitrogen Corporation
AnnaLee Saxsenian
Dean, School of Information, University of California, Berkeley
Christopher Scott
Executive Director, Stanford Program on Stem Cells and Society
Bernard Siegel
President, Genetics Policy Institute
Debora Spar
Senior Dean of Research, Harvard Business School
Susan Stayn
Member, Stanford Program on Stem Cells in Society
Irving Weissman
Director, Stanford University Institute for Regenerative Medicine
Dana Welch
Executive Director, Berkeley Program on Law, Technology and Society
Michael Werner
President, The Werner Group
Ian Wilmut
University of Edinburgh
Kevin Wilson
Director of Public Policy, American Society of Cell Biology
Celia Witten
Director, Office of Cellular, Tissue, and Gene Therapy, Center for Biologics Evaluation and Research, FDA
The registration cost is $1495 ($495 for academic and government registrants).
The event Clinical Trial Essentials–An Intensive Course at the University of California Extension, Santa Cruz at the Cupertino Campus on March 12-16, 2007. The program will examine the many facets of the clinical trial process. The program instructors will include:
- EUGENIA BUDMAN, who has over 20 years of industry experience, in roles including clinical data management and programming, clinical operations, project management, finance, software installation and development. She is currently the manager of the Data Management, Biostats and Systems groups at Abbott Vascular.
- R. MICHAEL CROMPTON, J.D., M.P.H., who is a regulatory affairs professional with over 20 years of experience in the medical device industry. He has held senior management positions at medical device start-ups as well as multi-national medical device corporations and practiced law at a leading food and drug law firm.
- MICHAEL HUSTON, M.B.A., who is the president of Huston Associates, LLC, has more than 20 years of experience in the life science industry, from basic research to strategic drug development. Mr. Huston has directed project teams through preclinical evaluations, Phase 1-3 clinical studies, and numerous regulatory submissions.
- JACQUIE MARDELL, B.A., who has more than 20 years of pharmaceutical and biotech industry experience in both large and small companies. She has a broad background in planning, implementation and analysis of Phase 1-4 clinical trials and has lead teams in the preparation and execution of clinical development place in a wide range of therapeutic areas.
- JEAN MASONEK, RN, B.S.N., who has worked in drug safety for a large multinational pharmaceutical corporation and mid-sized and small biotech companies in the Bay Area. She is currently drug safety manager at a small pharmaceutical company on the peninsula.
- FRANCES A. MCKENNEY, M.S., who is the director of GCP compliance at Genitope. Ms. McKenney has 20 years experience in the pharmaceutical/biotechnology industry working for both sponsor/manufacturers and a CRO.
- TAMMY MORTON-TAYLOR, M.S., who is a clinical project manager for Bailer Research, a contract research organization specializing in cardiovascular medical devices. She has 16 years of research experience, with more than 10 years devoted to coordinating, monitoring and managing clinical trials.
- NANETTE NANJO-JONES, M.B.A., who is the former director of contracts and proposals/business development for ICON Clinical Research, is now an independent outsourcing consultant. She has more than 12 years of experience in the biotechnology/pharmaceutical industry, from financial analysis to clinical-site budget negotiation and contracts management.
- EDWARD ROZHON, Ph.D., who is the senior manager of clinical trial management at Genentech and was formerly the associate director of development planning and program management at PPD Development. Dr. Rozhon has 18 years of pharmaceutical experience in preclinical and clinical areas of drug discovery and development.
- PETER SHABE, M.S., who is president of Advance Research Associates, Inc., a contract research organization (CRO) providing data-management and biostatistical services to medical-device, biotech and pharmaceutical industries.
The tuition for the course is |
$1,495.00. |
The event Startup-U SFO: Building a Clear & Significant Product Roadmap with Eric Walcyzkowski will take place on Thursday, March 8, 2007 at 11:45 a.m. at DLA Piper Rudnick, 153 Townsend Street, Suite 800 San Francisco, CA 94107. This program will address how entrepreneurs put together a clear product roadmap on how to get their products to market, focusing on the following:
- Defining the product that you would build to target that market
- Sizing the market
- Estimating the cost to develop and sell the product, and calculating a rough ROI
- How to take into account your team’s experience, and the learning curve
- Understanding the competition, and differentiation.
The featured speaker is Eric Walczykowski of Deloitte Ventures. The registration cost is $5 (member) or $15 (affiliate/non-member), plus a $1.50 credit card processing fee, and includes event and lunch, available through advanced online registration. A $10 or $20 fee is collected at the door.
Category:
Biotech Industry Events |
Comments Off on Startup-U SFO: Building a Clear & Significant Product Roadmap with Eric Walcyzkowski
The event Startup-U SFO: Building a Clear & Significant Product Roadmap with Eric Walcyzkowski will take place on Thursday, March 8, 2007 at 11:45 a.m. at DLA Piper Rudnick, 153 Townsend Street, Suite 800 San Francisco, CA 94107. This program will address how entrepreneurs put together a clear product roadmap on how to get their products to market, focusing on the following:
- Defining the product that you would build to target that market
- Sizing the market
- Estimating the cost to develop and sell the product, and calculating a rough ROI
- How to take into account your team’s experience, and the learning curve
- Understanding the competition, and differentiation.
The featured speaker is Eric Walczykowski of Deloitte Ventures. The registration cost is $5 (member) or $15 (affiliate/non-member), plus a $1.50 credit card processing fee, and includes event and lunch, available through advanced online registration. A $10 or $20 fee is collected at the door.
Category:
Biotech Industry Events |
Comments Off on Startup-U SFO: Building a Clear & Significant Product Roadmap with Eric Walcyzkowski
The event Nanotechnology in Drug Delivery-"How Close Are We?" will be held on Thursday, March 8, 2007 from 5:30-8:30 p.m. at Morrison & Foerster, 12531 High Bluff Drive, Suite 100, San Diego, CA 92130. This program will discuss some of the highlights of the major nano-enabled drug delivery technologies that are commercially available or under development. Participating speakers in the program will include Martin Woodle, Ph.D., Professor of Chemistry and Biochemistry, UC San Diego; Don Ackley, Ph.D., CEO, Nanotrop, Inc.; and Aartin Woodle, Ph.D., Chief Scientific Officer, Intradigm Corporation.
The event CALBIO/Annual Dinner 2007 will take place on March 6, 2007 from 7:00 – 9:00 p.m. at the San Diego Marriott & Marina, 333 W Harbor Drive, in San Diego, CA. CALBIO will provide a forum to learn from the experts and discuss best strategies for aligning FDA/CMS strategies. The topics include the following:
- The Crucial Alignment between the FDA and CMS;
- Financing your Innovation from Global Sources; NIH Funding: Will the new Congress stop the trend of declining budgets?; and
- Drug Manufacturing: Quality Compliance, Process Execution and Manufacturing Excellence.
CALBIO will also present a first hand report from the world’s top pharmaceutical companies of what exactly they are looking for in their upcoming licensing agreements, strategic partnerships, and acquisitions in 2007.
The event The 2nd Annual California Life Science Career Fair will take place on March 5, 2007 at the San Diego Marriott Hotel and Marina in San Diego, CA. This statewide career event will include the biotechnology, pharmaceutical and medical device industries, and it will give job seekers the opportunity to meet face-to-face with the region’s elite biopharmaceutical employers and interview for hundreds of open positions. BIOCOM and BioSpace will sponsor the event.
The event IBC’s 18th International Antibody Development & Production Successful Upstream and Downstream Processing Approaches will take place from February 28 – March 2, 2007 at La Costa Resort and Spa in Carlsbad, CA. This forum explores every critical stage of process and product development and is designed to help companies of all sizes accelerate their antibody therapeutic programs. The registration deadline for this event is December 15, 2006. For more information, contact IBC at 800.390.4078 (telephone); 941.365.0104 (fax); reg@ibcusa.com. The Priority Code is B4155BPIEM1.
Category:
Biotech Industry Events |
Comments Off on IBC’s 18th International Antibody Development & Production: Successful Upstream and Downstream Processing Approaches
The event IBC’s 18th International Antibody Development & Production Successful Upstream and Downstream Processing Approaches will take place from February 28 – March 2, 2007 at La Costa Resort and Spa in Carlsbad, CA. This forum explores every critical stage of process and product development and is designed to help companies of all sizes accelerate their antibody therapeutic programs. The registration deadline for this event is December 15, 2006. For more information, contact IBC at 800.390.4078 (telephone); 941.365.0104 (fax); reg@ibcusa.com. The Priority Code is B4155BPIEM1.
Category:
Biotech Industry Events |
Comments Off on IBC’s 18th International Antibody Development & Production: Successful Upstream and Downstream Processing Approaches